Results 1 to 5 of 24
Most popular |Most recent

Global perspectives - Preliminary injunctions in life sciences

Global - February 24 2021 What happens when a generic or biosimilar enters a market where patents are in force? What preliminary measures exist? On February 23, our…

Céline Bey, Daniela Shaw, Erin Creber, Paul Inman.

Second medical use patents part 2 - Verifying validity

Global - February 1 2021 What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something…

Vladislav Ugryumov, Alex Gloor, Jian Xu, Paul Inman.

Second medical use patent series: Understanding infringement and enforcement

United Kingdom - January 22 2021 As the scientific community continues to tackle some of the world's most challenging diseases, research and innovation has led to the discovery of new…

Vladislav Ugryumov, Alex Gloor, Jian Xu, Paul Inman.

Amendments to the Patented Medicines Regulations delayed by

Canada - December 31 2020 The coming-into-force date of the Regulations Amending the Patented Medicines Regulations ("the Amendments") has been delayed by 6 months until July 1…

Alex Gloor, Jenny Thistle.

Optimizing life sciences patents: Top tips from gowling wlg's global ip professionals

Global - June 23 2020 To ensure your patent catches potential infringements in the future, you must plan carefully and pay close attention to patent drafting. How is the…

Jian Xu, Paul Inman, Ruben Dzhermakyan, Sonia M. Ziesche.